Eli Lily

Showing 3 posts of 3 posts found.


Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint

April 9, 2021
Medical Communications COVID-19, Eli Lily

Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …


Lily increases diabetes drug by 700% over 20 years

November 3, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …

Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk

August 5, 2016
Medical Communications, Research and Development Eli Lily, Novo Nordisk, Victoza, diabetes, heart failure

Novo Nordisk’s diabetes drug Victoza (liraglutide), which was found to cut cardiovascular risks in sufferers of heart disease, has failed …

Latest content